The Effects of Risk Disclosure in Direct-to-Consumer Prescription Drug Advertising (DTCA): Prominence, DTCA Regulatory Knowledge, and Perceived Attention

作者: Ilwoo Ju

DOI:

关键词:

摘要:

参考文章(232)
Carl Obermiller, Eric R. Spangenberg, On the Origin and Distinctness of Skepticism toward Advertising Marketing Letters. ,vol. 11, pp. 311- 322 ,(2000) , 10.1023/A:1008181028040
Ventola Cl, Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic? P & T : a peer-reviewed journal for formulary management. ,vol. 36, pp. 669- 684 ,(2011)
Wendy Macias, Liza Stavchansky Lewis, Tae Hyun Baek, The Changing Face of Direct-to-Consumer Print Advertising Pharmaceutical medicine. ,vol. 24, pp. 165- 177 ,(2010) , 10.1007/BF03256813
Ronald E. Taylor, A Six-Segment Message Strategy Wheel Journal of Advertising Research. ,vol. 39, pp. 7- 7 ,(1999)
Eric S. Knowles, Resistance and Persuasion Psychology Press. pp. 83- 104 ,(2004) , 10.4324/9781410609816
J. Craig Andrews, Warnings and Disclosures: Special Editor's Note Journal of Public Policy & Marketing. ,vol. 17, pp. 1- 2 ,(1998) , 10.1177/074391569801700101
Alex Poole, Linden J. Ball, Eye tracking in HCI and usability research. Idea Group Inc.. pp. 211- 219 ,(2006) , 10.4018/978-1-59140-562-7.CH034